Showing results (261-270 of 1,557) with videos related to

Sort By:
Pageof 156
Gastroenterologie Clinique Et Biologique|January 3, 2009
TNF antagonists in the treatment of inflammatory bowel disease: results of a survey of gastroenterologists in the French region of LorraineL Peyrin-Biroulet, A Oussalah, T Boucekkine, et al.
Inflammatory Bowel Diseases|July 20, 2007
IBD serological panels: facts and perspectivesLaurent Peyrin-Biroulet, Annie Standaert-Vitse, Julien Branche, et al.
Revue De Stomatologie Et De Chirurgie Maxillo-Faciale|January 1, 1979
[Sialorrhea. Value of isotopic examination (author's transl)]P Cros, J Parret, J Peyrin, et al.
Frontiers in Chemistry|September 1, 2015
Ultrafast capillary electrophoresis isolation of DNA aptamer for the PCR amplification-based small analyte sensingEmmanuelle Fiore, Eric Dausse, Hervé Dubouchaud, et al.
Analytica Chimica Acta|January 3, 2018
Mirror-image aptamer kissing complex for arginine-vasopressin sensingBenoit Chovelon, Emmanuelle Fiore, Patrice Faure, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 13, 2016
Cancer and inflammatory bowel disease in the elderlySasha Taleban, Emad Elquza, Corinne Gower-Rousseau, et al.
Plos One|June 8, 2012
Is coarse-to-fine strategy sensitive to normal aging?Benoit Musel, Alan Chauvin, Nathalie Guyader, et al.
Hearing Research|May 30, 1998
Specific sound-induced noradrenergic and serotonergic activation in central auditory structuresH Cransac, J M Cottet-Emard, S Hellström, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 3, 2020
Treat to Target: The Role of Histologic Healing in Inflammatory Bowel Diseases: A Systematic Review and Meta-analysisAkshita Gupta, Amy Yu, Laurent Peyrin-Biroulet, et al.
Expert Opinion on Biological Therapy|December 10, 2019
Evolving primary and secondary endpoints in randomized controlled trials leading to approval of biologics and small molecules in IBD: an historical perspectivePatrick B Allen, Stefanos Bonovas, Silvio Danese, et al.
Pageof 156